Endocrinology, Vol 137, 2187-2190, Copyright © 1996 by Endocrine Society

ARTICLES

Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact [corrected and republished in Endocrinology 1996 Aug;137(8)2187-90]

E Jimi, I Nakamura, H Amano, Y Taguchi, T Tsurukai, M Tamura, N Takahashi and T Suda
Department of Biochemistry, School of Dentistry, Showa University, Tokyo, Japan.

We have established a method for obtaining an enriched preparation of functionally active osteoclast-like multinucleated cells (enriched OCLs) from co-cultures of mouse primary osteoblasts and bone marrow cells. Using these enriched OCLs, the effect of osteoblastic cells on osteoclast function was examined in two assays: a pit formation assay and an assay for actin ring formation. The enriched OCLs cultured for 24 h on dentine slices formed only a few resorption pits. When various numbers of primary osteoblasts were added to the enriched OCLs, the areas of the resorption pits increased proportionally to the number of osteoblasts added. Like primary osteoblasts, the established cell lines of osteoblastic cells (MC3T3-E1 and KS-4) and bone marrow-derived stromal cells (MC3T3-G2/PA6 and ST2) potentiated the pit formation caused by enriched OCLs. In contrast, the fibroblastic cell lines NIH3T3 and C3H10T1/2) and the myoblastic cell line (C2C12) failed to activate OCL function. When cell-to-cell contact between MC3T3-E1 cells and enriched OCLs was prevented, only a few resorption pits were formed. Pit formation by enriched rat osteoclasts placed on dentine slices was also stimulated by adding MC3T3-E1 cells. Actin ring formation and pit forming activity were well correlated in either culture of enriched mouse OCLs or authentic rat osteoclasts on dentine slices. These results indicate that osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell and/or cell-to matrix contact.

This article has been cited by other articles:

				M. G. Ruocco, S. Maeda, J. M. Park, T. Lawrence, L.-C. Hsu, Y. Cao, G. Schett, E. F. Wagner, and M. Karin I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss J. Exp. Med., May 16, 2005; 201(10): 1677 - 1687. [Abstract] [Full Text] [PDF]

				W. Zou, A. Amcheslavsky, and Z. Bar-Shavit CpG Oligodeoxynucleotides Modulate the Osteoclastogenic Activity of Osteoblasts via Toll-like Receptor 9 J. Biol. Chem., May 2, 2003; 278(19): 16732 - 16740. [Abstract] [Full Text] [PDF]

				H Sakai, S Jingushi, T Shuto, K Urabe, T Ikenoue, K Okazaki, T Kukita, A Kukita, and Y Iwamoto Fibroblasts from the inner granulation tissue of the pseudocapsule in hips at revision arthroplasty induce osteoclast differentiation, as do stromal cells Ann Rheum Dis, February 1, 2002; 61(2): 103 - 109. [Abstract] [Full Text] [PDF]

				D. Grcevic, S.-K. Lee, A. Marusic, and J. A. Lorenzo Depletion of CD4 and CD8 T Lymphocytes in Mice In Vivo Enhances 1,25-Dihydroxyvitamin D3-Stimulated Osteoclast-Like Cell Formation In Vitro by a Mechanism That Is Dependent on Prostaglandin Synthesis J. Immunol., October 15, 2000; 165(8): 4231 - 4238. [Abstract] [Full Text] [PDF]

				M. N. Weitzmann, S. Cenci, L. Rifas, C. Brown, and R. Pacifici Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines Blood, September 1, 2000; 96(5): 1873 - 1878. [Abstract] [Full Text] [PDF]

				K. Kobayashi, N. Takahashi, E. Jimi, N. Udagawa, M. Takami, S. Kotake, N. Nakagawa, M. Kinosaki, K. Yamaguchi, N. Shima, et al. Tumor Necrosis Factor {alpha} Stimulates Osteoclast Differentiation by a Mechanism Independent of the ODF/RANKL-RANK Interaction J. Exp. Med., January 17, 2000; 191(2): 275 - 286. [Abstract] [Full Text] [PDF]

				E. Jimi, S. Akiyama, T. Tsurukai, N. Okahashi, K. Kobayashi, N. Udagawa, T. Nishihara, N. Takahashi, and T. Suda Osteoclast Differentiation Factor Acts as a Multifunctional Regulator in Murine Osteoclast Differentiation and Function J. Immunol., July 1, 1999; 163(1): 434 - 442. [Abstract] [Full Text] [PDF]

				T. Suda, N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, and T. J. Martin Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families Endocr. Rev., June 1, 1999; 20(3): 345 - 357. [Abstract] [Full Text]

				T. L. Burgess, Y.-x. Qian, S. Kaufman, B. D. Ring, G. Van, C. Capparelli, M. Kelley, H. Hsu, W. J. Boyle, C. R. Dunstan, et al. The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature Osteoclasts J. Cell Biol., May 3, 1999; 145(3): 527 - 538. [Abstract] [Full Text] [PDF]

				D. M. Biskobing, D. Fan, X. Fan, and J. Rubin Induction of Carbonic Anhydrase II Expression in Osteoclast Progenitors Requires Physical Contact with Stromal Cells Endocrinology, November 1, 1997; 138(11): 4852 - 4857. [Abstract] [Full Text] [PDF]